Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 296

1.

TRPM7 channels mediate spontaneous Ca2+ fluctuations in growth plate chondrocytes that promote bone development.

Qian N, Ichimura A, Takei D, Sakaguchi R, Kitani A, Nagaoka R, Tomizawa M, Miyazaki Y, Miyachi H, Numata T, Kakizawa S, Nishi M, Mori Y, Takeshima H.

Sci Signal. 2019 Apr 9;12(576). pii: eaaw4847. doi: 10.1126/scisignal.aaw4847.

PMID:
30967513
2.

Long-term Changes in Renal Function, Blood Electrolyte Levels, and Nutritional Indices after Radical Cystectomy and Ileal Conduit in Patients with Bladder Cancer.

Miyake M, Owari T, Tomizawa M, Matsui M, Nishibayashi N, Iida K, Onishi K, Hori S, Morizawa Y, Gotoh D, Itami Y, Nakai Y, Inoue T, Anai S, Torimoto K, Aoki K, Tanaka N, Fujimoto K.

Urol J. 2019 May 5;16(2):145-151. doi: 10.22037/uj.v0i0.4531.

3.

Clinical benefit of early treatment with bone-modifying agents for preventing skeletal-related events in patients with genitourinary cancer with bone metastasis: A multi-institutional retrospective study.

Owari T, Miyake M, Nakai Y, Hori S, Tomizawa M, Ichikawa K, Shimizu T, Iida K, Samma S, Iemura Y, Momose H, Omori C, Otani T, Kuwada M, Hirao S, Oyama N, Nakagawa Y, Hayashi Y, Tanaka N, Fujimoto K.

Int J Urol. 2019 Jun;26(6):630-637. doi: 10.1111/iju.13939. Epub 2019 Mar 18.

PMID:
30883931
4.

Serum cytokine profiles and Mac-2 binding protein glycosylation isomer (M2BPGi) level in patients with autoimmune hepatitis.

Migita K, Horai Y, Kozuru H, Koga T, Abiru S, Yamasaki K, Komori A, Fujita Y, Asano T, Sato S, Suzuki E, Matsuoka N, Kobayashi H, Watanabe H, Naganuma A, Naeshiro N, Yoshizawa K, Ohta H, Sakai H, Shimada M, Nishimura H, Tomizawa M, Ario K, Yamashita H, Kamitsukasa H, Kohno H, Nakamura M, Furukawa H, Takahashi A, Kawakami A, Ohira H, Yastuhashi H.

Medicine (Baltimore). 2018 Dec;97(50):e13450. doi: 10.1097/MD.0000000000013450.

5.

[A Case of Rheumatoid Arthritis Developed during Treatment with Nivolumab for Renal Cell Carcinoma].

Tomizawa M, Nakai Y, Maesaka F, Owari T, Hara R, Miyake M, Inoue T, Anai S, Tanaka N, Fujimoto K.

Hinyokika Kiyo. 2018 Oct;64(10):397-401. doi: 10.14989/ActaUrolJap_64_10_397. Review. Japanese.

PMID:
30543737
6.

Adverse pregnancy and perinatal outcome in patients with recurrent pregnancy loss: Multiple imputation analyses with propensity score adjustment applied to a large-scale birth cohort of the Japan Environment and Children's Study.

Sugiura-Ogasawara M, Ebara T, Yamada Y, Shoji N, Matsuki T, Kano H, Kurihara T, Omori T, Tomizawa M, Miyata M, Kamijima M, Saitoh S; Japan Environment, Children’s Study (JECS) Group.

Am J Reprod Immunol. 2019 Jan;81(1):e13072. doi: 10.1111/aji.13072. Epub 2018 Dec 13.

PMID:
30430678
7.

Oct3/4 is potentially useful for the suppression of the proliferation and motility of hepatocellular carcinoma cells.

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Oncol Lett. 2018 Oct;16(4):5243-5248. doi: 10.3892/ol.2018.9292. Epub 2018 Aug 10.

8.

Association of a single nucleotide polymorphism in TNIP1 with type-1 autoimmune hepatitis in the Japanese population.

Oka S, Higuchi T, Furukawa H, Nakamura M, Komori A, Abiru S, Nagaoka S, Hashimoto S, Naganuma A, Naeshiro N, Yoshizawa K, Shimada M, Nishimura H, Tomizawa M, Kikuchi M, Makita F, Yamashita H, Ario K, Yatsuhashi H, Tohma S, Kawasaki A, Tsuchiya N, Migita K.

J Hum Genet. 2018 Jun;63(6):739-744. doi: 10.1038/s10038-018-0440-0. Epub 2018 Mar 20.

PMID:
29559739
9.

Unexpected presentation of allograft dysfunction triggered by page kidney phenomenon immediately after kidney transplantation: a case report.

Hori S, Tomizawa M, Maesaka F, Owari T, Morizawa Y, Nakai Y, Miyake M, Yoneda T, Tanaka N, Yoshida K, Fujimoto K.

BMC Nephrol. 2018 Mar 13;19(1):59. doi: 10.1186/s12882-018-0860-2.

10.

Epididymal phospholipidosis is a possible mechanism for spermatotoxicity induced by the organophosphorus insecticide fenitrothion in rats.

Miyake M, Ito Y, Suzuki H, Tomizawa M, Sato H, Liu M, Okamura A, Nakajima T, Ohtani K, Takino H, Inagaki H, Kamijima M.

Toxicol Lett. 2018 Mar 15;285:27-33. doi: 10.1016/j.toxlet.2017.12.023. Epub 2017 Dec 30.

PMID:
29292090
11.

Comparison of DWIBS/T2 image fusion and PET/CT for the diagnosis of cancer in the abdominal cavity.

Tomizawa M, Shinozaki F, Uchida Y, Uchiyama K, Tanaka S, Sunaoshi T, Kano D, Sugiyama E, Shite M, Haga R, Fukamizu Y, Fujita T, Kagayama S, Hasegawa R, Shirai Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Exp Ther Med. 2017 Oct;14(4):3754-3760. doi: 10.3892/etm.2017.4987. Epub 2017 Aug 22.

12.

Flupyrimin: A Novel Insecticide Acting at the Nicotinic Acetylcholine Receptors.

Onozaki Y, Horikoshi R, Ohno I, Kitsuda S, Durkin KA, Suzuki T, Asahara C, Hiroki N, Komabashiri R, Shimizu R, Furutani S, Ihara M, Matsuda K, Mitomi M, Kagabu S, Uomoto K, Tomizawa M.

J Agric Food Chem. 2017 Sep 13;65(36):7865-7873. doi: 10.1021/acs.jafc.7b02924. Epub 2017 Aug 28.

PMID:
28820587
13.

Hepatocyte selection medium-enriched hepatocellular carcinoma cells are positive for α-fetoprotein and CD44.

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Oncol Lett. 2017 Jul;14(1):899-902. doi: 10.3892/ol.2017.6239. Epub 2017 May 24.

14.

Diagnosis of complications associated with acute cholecystitis using computed tomography and diffusion-weighted imaging with background body signal suppression/T2 image fusion.

Tomizawa M, Shinozaki F, Tanaka S, Sunaoshi T, Kano D, Sugiyama E, Shite M, Haga R, Fukamizu Y, Fujita T, Kagayama S, Hasegawa R, Shirai Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Exp Ther Med. 2017 Jul;14(1):743-747. doi: 10.3892/etm.2017.4567. Epub 2017 Jun 8.

15.

Diffusion-weighted whole-body magnetic resonance imaging with background body signal suppression/T2 image fusion for the diagnosis of acute cholecystitis.

Tomizawa M, Shinozaki F, Tanaka S, Sunaoshi T, Kano D, Sugiyama E, Shite M, Haga R, Fukamizu Y, Fujita T, Kagayama S, Hasegawa R, Shirai Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Exp Ther Med. 2017 Jul;14(1):730-734. doi: 10.3892/etm.2017.4561. Epub 2017 Jun 8.

16.

CCAAT/enhancer-binding protein α decreases the viability of gastric cancer cells.

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Oncol Lett. 2017 Jun;13(6):4322-4326. doi: 10.3892/ol.2017.5987. Epub 2017 Apr 5.

17.

Diagnostic accuracy of diffusion-weighted whole-body imaging with background body signal suppression/T2-weighted image fusion for the detection of abdominal solid cancer.

Tomizawa M, Shinozaki F, Fugo K, Tanaka S, Sunaoshi T, Kano D, Sugiyama E, Shite M, Haga R, Fukamizu Y, Fujita T, Kagayama S, Hasegawa R, Togawa A, Shirai Y, Ichiki N, Oshima Y, Koike N, Toshimitsu Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Kishimoto T, Ishige N.

Exp Ther Med. 2017 Jun;13(6):3509-3515. doi: 10.3892/etm.2017.4432. Epub 2017 May 5.

18.

Comparison of acute cholangitis with or without common bile duct dilatation.

Tomizawa M, Shinozaki F, Hasegawa R, Shirai Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Exp Ther Med. 2017 Jun;13(6):3497-3502. doi: 10.3892/etm.2017.4401. Epub 2017 Apr 28.

19.

Abdominal ultrasonography for patients with abdominal pain as a first-line diagnostic imaging modality.

Tomizawa M, Shinozaki F, Hasegawa R, Shirai Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Exp Ther Med. 2017 May;13(5):1932-1936. doi: 10.3892/etm.2017.4209. Epub 2017 Mar 9.

20.

Immunosuppressive agents are associated with peptic ulcer bleeding.

Tomizawa M, Shinozaki F, Hasegawa R, Shirai Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Exp Ther Med. 2017 May;13(5):1927-1931. doi: 10.3892/etm.2017.4214. Epub 2017 Mar 9.

21.

Introduction of plasmids into gastric cancer cells by endoscopic ultrasound.

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Oncol Lett. 2017 May;13(5):3127-3130. doi: 10.3892/ol.2017.5836. Epub 2017 Mar 10.

22.

Proliferation and motility of hepatocellular, pancreatic and gastric cancer cells grown in a medium without glucose and arginine, but with galactose and ornithine.

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Oncol Lett. 2017 Mar;13(3):1276-1280. doi: 10.3892/ol.2017.5568. Epub 2017 Jan 4.

23.

Proliferation of sphere-forming hepatocellular carcinoma cells is suppressed in a medium without glucose and arginine, but with galactose and ornithine.

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Oncol Lett. 2017 Mar;13(3):1264-1268. doi: 10.3892/ol.2017.5565. Epub 2017 Jan 2.

24.

Differentiation of human induced pluripotent stem cells in William's E initiation medium supplemented with 3‑bromopyruvate and 2‑deoxy‑d‑glucose.

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Mol Med Rep. 2017 Jun;15(6):3719-3723. doi: 10.3892/mmr.2017.6474. Epub 2017 Apr 12.

PMID:
28440498
25.

2‑Deoxy‑D‑glucose initiates hepatocyte differentiation in human induced pluripotent stem cells.

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Mol Med Rep. 2017 May;15(5):3083-3087. doi: 10.3892/mmr.2017.6405. Epub 2017 Mar 28.

PMID:
28358426
26.

Oncostatin M in William's E medium is suitable for initiation of hepatocyte differentiation in human induced pluripotent stem cells.

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Mol Med Rep. 2017 May;15(5):3088-3092. doi: 10.3892/mmr.2017.6406. Epub 2017 Mar 28.

PMID:
28358419
27.

2-Deoxyglucose and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells.

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Oncol Lett. 2017 Feb;13(2):800-804. doi: 10.3892/ol.2016.5510. Epub 2016 Dec 16.

28.

Diffusion-weighted whole-body imaging with background body signal suppression/T2 image fusion for the diagnosis of colorectal polyp and cancer.

Tomizawa M, Shinozaki F, Uchida Y, Uchiyama K, Fugo K, Sunaoshi T, Ozaki A, Sugiyama E, Baba A, Kano D, Shite M, Haga R, Fukamizu Y, Kagayama S, Hasegawa R, Shirai Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Kishimoto T, Ishige N.

Exp Ther Med. 2017 Feb;13(2):639-644. doi: 10.3892/etm.2016.3981. Epub 2016 Dec 16.

29.

[A Case of a Large Gastric Gastrointestinal Stromal Tumor with a PDGFRA Exon 18 Mutation].

Imagawa A, Tomizawa M, Okumura S, Toyoda S, Kawashima H, Yamamoto K, Ito A, Mizumura N, Yoo K, Maehira H, Ogawa M, Kawasaki M, Kameyama M, Yoshimura M, Hirota S.

Gan To Kagaku Ryoho. 2016 Nov;43(12):1878-1880. Japanese.

PMID:
28133162
30.

Cell death in a co-culture of hepatocellular carcinoma cells and human umbilical vascular endothelial cells in a medium lacking glucose and arginine.

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Oncol Lett. 2017 Jan;13(1):258-262. doi: 10.3892/ol.2016.5454. Epub 2016 Nov 30.

31.

Unenhanced areas revealed by contrast-enhanced abdominal ultrasonography with Sonazoid™ potentially correspond to colorectal cancer.

Tomizawa M, Togashi M, Shinozaki F, Hasegawa R, Shirai Y, Noritake M, Matsuoka Y, Kainuma H, Iwasaki Y, Fugo K, Motoyoshi Y, Sugiyama T, Yamamoto S, Kishimoto T, Ishige N.

Exp Ther Med. 2016 Dec;12(6):4012-4016. doi: 10.3892/etm.2016.3868. Epub 2016 Nov 3.

32.

Association of a single nucleotide polymorphism upstream of ICOS with Japanese autoimmune hepatitis type 1.

Higuchi T, Oka S, Furukawa H, Nakamura M, Komori A, Abiru S, Nagaoka S, Hashimoto S, Naganuma A, Naeshiro N, Yoshizawa K, Shimada M, Nishimura H, Tomizawa M, Kikuchi M, Makita F, Yamashita H, Ario K, Yatsuhashi H, Tohma S, Kawasaki A, Ohira H, Tsuchiya N, Migita K.

J Hum Genet. 2017 Apr;62(4):481-484. doi: 10.1038/jhg.2016.155. Epub 2016 Dec 15.

PMID:
27974812
33.

Isolation of botulinolysin, a thiol-activated hemolysin, from serotype D Clostridium botulinum: A species-specific gene duplication in Clostridia.

Suzuki T, Nagano T, Niwa K, Mutoh S, Uchino M, Tomizawa M, Sagane Y, Watanabe T.

Microbiol Res. 2016 Dec;193:20-29. doi: 10.1016/j.micres.2016.08.011. Epub 2016 Aug 23.

34.

Construction of "Toxin Complex" in a Mutant Serotype C Strain of Clostridium botulinum Harboring a Defective Neurotoxin Gene.

Suzuki T, Nagano T, Niwa K, Uchino M, Tomizawa M, Sagane Y, Watanabe T.

Curr Microbiol. 2017 Jan;74(1):49-54. doi: 10.1007/s00284-016-1150-5. Epub 2016 Oct 26.

PMID:
27785552
35.

Signal Intensity of Superb Microvascular Imaging Correlates with the Severity of Acute Cholecystitis.

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Case Rep Gastroenterol. 2016 Aug 31;10(2):452-458. eCollection 2016 May-Aug.

36.

Change ratio of hemoglobin has predictive value for upper gastrointestinal bleeding.

Tomizawa M, Shinozaki F, Hasegawa R, Shirai Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Biomed Rep. 2016 Oct;5(4):479-482. Epub 2016 Sep 8.

37.

Zero-valent iron treatment of dark brown colored coffee effluent: Contributions of a core-shell structure to pollutant removals.

Tomizawa M, Kurosu S, Kobayashi M, Kawase Y.

J Environ Manage. 2016 Dec 1;183(Pt 3):478-487. doi: 10.1016/j.jenvman.2016.08.081. Epub 2016 Sep 9.

PMID:
27623374
38.

Low hemoglobin levels are associated with upper gastrointestinal bleeding.

Tomizawa M, Shinozaki F, Hasegawa R, Shirai Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Biomed Rep. 2016 Sep;5(3):349-352. Epub 2016 Jul 27.

39.

A Case of Gastrointestinal Stromal Tumor That Underwent Endoscopic Ultrasound-Guided Aspiration with a 25-Gauge Biopsy Needle.

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Case Rep Gastroenterol. 2016 May 9;10(1):168-73. doi: 10.1159/000443269. eCollection 2016 Jan-Apr.

40.

Duodenal Adenocarcinoma Diagnosed from a Biopsy Specimen of a Depressed Lesion Obtained by Magnifying Endoscopy.

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Case Rep Gastroenterol. 2016 May 4;10(1):161-7. doi: 10.1159/000444441. eCollection 2016 Jan-Apr.

41.

Characteristics of colorectal cancer diagnosed with screening abdominal ultrasonography.

Tomizawa M, Shinozaki F, Hasegawa R, Fugo K, Shirai Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Kishimoto T, Ishige N.

Mol Clin Oncol. 2016 Jul;5(1):64-68. Epub 2016 May 11.

42.

Diffusion-weighted whole-body imaging with background body signal suppression/T2-weighted image fusion of gastrointestinal cancers.

Tomizawa M, Shinozaki F, Fugo K, Sunaoshi T, Kano D, Tanaka S, Ozaki A, Sugiyama E, Shite M, Haga R, Baba A, Fukamizu Y, Fujita T, Kagayama S, Hasegawa R, Togawa A, Shirai Y, Ichiki N, Motoyoshi Y, Sugiyama T, Yamamoto S, Kishimoto T, Ishige N.

Mol Clin Oncol. 2016 Jul;5(1):44-48. Epub 2016 May 11.

43.

Characterization of the activity of β-galactosidase from Escherichia coli and Drosophila melanogaster in fixed and non-fixed Drosophila tissues.

Tomizawa M, Tsumaki K, Sone M.

Biochim Open. 2016 Jun 22;3:1-7. doi: 10.1016/j.biopen.2016.06.001. eCollection 2016 Dec.

44.

Elevated C-reactive protein level predicts lower gastrointestinal tract bleeding.

Tomizawa M, Shinozaki F, Hasegawa R, Shirai Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Biomed Rep. 2016 Jun;4(6):711-714. Epub 2016 Apr 13.

45.

Negative signals for adenomyomatosis of the gallbladder upon diffusion-weighted whole body imaging with background body signal suppression/T2-weighted image fusion analysis.

Tomizawa M, Shinozaki F, Fugo K, Sunaoshi T, Sugiyama E, Kano D, Shite M, Haga R, Fukamizu Y, Kagayama S, Hasegawa R, Shirai Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Kishimoto T, Ishige N.

Exp Ther Med. 2016 May;11(5):1777-1780. Epub 2016 Mar 2.

46.

Improved Survival and Initiation of Differentiation of Human Induced Pluripotent Stem Cells to Hepatocyte-Like Cells upon Culture in William's E Medium followed by Hepatocyte Differentiation Inducer Treatment.

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

PLoS One. 2016 Apr 13;11(4):e0153435. doi: 10.1371/journal.pone.0153435. eCollection 2016.

47.

Niclosamide suppresses migration of hepatocellular carcinoma cells and downregulates matrix metalloproteinase-9 expression.

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Oncol Lett. 2015 Dec;10(6):3515-3518. Epub 2015 Oct 9.

48.

Transcription Factors and Medium Suitable for Initiating the Differentiation of Human-Induced Pluripotent Stem Cells to the Hepatocyte Lineage.

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

J Cell Biochem. 2016 Sep;117(9):2001-9. doi: 10.1002/jcb.25494. Epub 2016 Feb 2.

PMID:
26773721
49.

Association between colon diverticula and hemoglobin, triglyceride and uric acid levels.

Tomizawa M, Shinozaki F, Hasegawa R, Shirai Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Exp Ther Med. 2015 Dec;10(6):2157-2160. Epub 2015 Oct 15.

50.

Lack of association between the CARD10 rs6000782 polymorphism and type 1 autoimmune hepatitis in a Japanese population.

Migita K, Jiuchi Y, Furukawa H, Nakamura M, Komori A, Yasunami M, Kozuru H, Abiru S, Yamasaki K, Nagaoka S, Hashimoto S, Bekki S, Yoshizawa K, Shimada M, Kouno H, Kamitsukasa H, Komatsu T, Hijioka T, Nakamuta M, Naganuma A, Yamashita H, Nishimura H, Ohta H, Nakamura Y, Ario K, Oohara Y, Sugi K, Tomizawa M, Sato T, Takahashi H, Muro T, Makita F, Mita E, Sakai H, Yatsuhashi H.

BMC Res Notes. 2015 Dec 12;8:777. doi: 10.1186/s13104-015-1733-4.

Supplemental Content

Loading ...
Support Center